Nikolaus Schultz
Impact in
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 0.05%
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 71
-
- Bioinformatics and Genomic Networks 20
- Co-authors
- Chris Sander (43 shared papers)Ethan Cerami (9 shared papers)Bülent Arman Aksoy (10 shared papers)Anders J. Skanderup (10 shared papers)Jianjiong Gao (23 shared papers)S. Onur Sumer (7 shared papers)Erik Larsson (4 shared papers)Uğur Doğrusöz (4 shared papers)
- Journals
- Journal of Clinical Oncology (49 papers)Cancer Research (15 papers)Clinical Cancer Research (13 papers)Cancer Discovery (7 papers)PLoS ONE (6 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Nikolaus Schultz
215 papers receiving 39.5k citations
Nikolaus Schultz's Hit Papers
Peers
Comparison fields: 5 of 174
- Cancer Research 10.3k
- Oncology 9.4k
- Molecular Biology 21.4k
- Pulmonary and Respiratory Medicine 7.7k
- Pathology and Forensic Medicine 3.2k
Countries citing papers authored by Nikolaus Schultz
This map shows the geographic impact of Nikolaus Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaus Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaus Schultz more than expected).
Fields of papers citing papers by Nikolaus Schultz
This network shows the impact of papers produced by Nikolaus Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaus Schultz. The network helps show where Nikolaus Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Nikolaus Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data Hit paper breakdown → | 2012 | 12203 |
| 2 | Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal Hit paper breakdown → | 2013 | 10972 |
| 3 | Evaluating cell lines as tumour models by comparison of genomic profiles Hit paper breakdown → | 2013 | 1079 |
| 4 | Emerging landscape of oncogenic signatures across human cancers Hit paper breakdown → | 2013 | 921 |
| 5 | Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers Hit paper breakdown → | 2016 | 886 |
| 6 | Pathway Commons, a web resource for biological pathway data Hit paper breakdown → | 2010 | 769 |
| 7 | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity Hit paper breakdown → | 2015 | 500 |
| 8 | 2003 | 479 | |
| 9 | Mutual exclusivity analysis identifies oncogenic network modules Hit paper breakdown → | 2011 | 460 |
| 10 | Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping Hit paper breakdown → | 2015 | 425 |
| 11 | A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) Hit paper breakdown → | 2018 | 418 |
| 12 | Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention Hit paper breakdown → | 2018 | 386 |
| 13 | Genome doubling shapes the evolution and prognosis of advanced cancers Hit paper breakdown → | 2018 | 358 |
| 14 | 2014 | 353 | |
| 15 | 2013 | 308 | |
| 16 | 2014 | 269 | |
| 17 | 2013 | 268 | |
| 18 | Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets Hit paper breakdown → | 2017 | 265 |
| 19 | 2019 | 261 | |
| 20 | 2010 | 260 |
About Nikolaus Schultz
Nikolaus Schultz is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 233 papers that have together received 39.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (71 papers), Genetic factors in colorectal cancer (30 papers), Prostate Cancer Treatment and Research (20 papers), Bioinformatics and Genomic Networks (20 papers), Lung Cancer Treatments and Mutations (16 papers), Colorectal Cancer Treatments and Studies (14 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Gastric Cancer Management and Outcomes (13 papers). The work is most often cited by research in Cancer Research (10.3k citations), Oncology (9.4k citations), Molecular Biology (21.4k citations), Pulmonary and Respiratory Medicine (7.7k citations) and Pathology and Forensic Medicine (3.2k citations). Nikolaus Schultz has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Chris Sander, Ethan Cerami, Bülent Arman Aksoy, Anders J. Skanderup, Jianjiong Gao, S. Onur Sumer, Erik Larsson, Uğur Doğrusöz, Benjamin Groß and Rileen Sinha. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Cancer Discovery and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.